Elevated levels of IL-1β in diabetes activate the expression of other inflammatory cytokines and amplify the pro-inflammatory milieu, temporarily increase insulin secretion, which may be detrimental to metabolism [50,51]. This evidence concerns the gene INS and diabetes mellitus.